Does Locoregional Treatment in de Novo Stage IV Bone-Only Metastatic Breast Cancer Prolong Survival? An Ongoing Multicenter Registry Study

被引：0
|
作者：
Soran, Atilla
Isik, Arda
Dogan, Lutfi
Sezgin, Efe
Ozbas, Serdar
机构：
[1] Erzincan Univ, Sch Med, Erzincan, Turkey
[2] Guven Hastanesi, Ankara, Turkey
[3] IzTech, Izmir, Turkey
[4] Saglik Bilimleri Univ, Abdurrahman Yurtaslan Ankara Onkol SUAM, Ankara, Turkey
[5] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2019年 / 229卷 / 04期
关键词：
D O I：
10.1016/j.jamcollsurg.2019.08.877
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：E5 / E5
页数：1
相关论文
共 50 条
  • [41] Could local surgery improve survival in de novo stage IV breast cancer?
    Zhenchong Xiong
    Guangzheng Deng
    Jin Wang
    Xing Li
    Xinhua Xie
    Zeyu Shuang
    Xi Wang
    BMC Cancer, 18
  • [42] Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: A real-world observational study
    Wang, Kang
    Shi, Yang
    Li, Zhu-Yue
    Xiao, Ye-Lei
    Li, Jie
    Zhang, Xiang
    Li, Hong-Yuan
    EJSO, 2019, 45 (08): : 1364 - 1372
  • [43] The impact of breast surgery and systemic therapy on the survival of patients with de novo stage IV breast cancer
    Tokunaga, Eriko
    Koi, Yumiko
    Tajiri, Wakako
    Koga, Chinami
    Ijichi, Hideki
    Akiyoshi, Sayuri
    Kawasaki, Junji
    Nakamura, Yoshiaki
    Taguchi, Kenichi
    Okamoto, Masahiro
    BREAST CANCER, 2025, 32 (02) : 426 - 433
  • [44] Do We Consider Locoregional Treatment of Primary Site in Patients With De Novo Stage IV Breast Cancer?: Numerous Data Are Accumulating!
    Altundag, Kadri
    CLINICAL BREAST CANCER, 2018, 18 (03) : E299 - E299
  • [45] First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better?
    Toss, A.
    Venturelli, M.
    Sperduti, I.
    Isca, C.
    Barbieri, E.
    Piacentini, F.
    Omarini, C.
    Cortesi, L.
    Cascinu, S.
    Moscetti, L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [46] Use of locoregional treatment to improve survival in de novo stage IV breast cancer patients with luminal-like and HER2-rich subtypes.
    Chen, Pengyu
    Cheng, Skye H. Hong-Chun
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [47] First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better?
    Toss, A.
    Venturelli, M.
    Sperduti, I.
    Isca, C.
    Molinaro, E.
    Barbieri, E.
    Piacentini, F.
    Omarini, C.
    Cortesi, L.
    Cascinu, S.
    Moscetti, L.
    CANCER RESEARCH, 2019, 79 (04)
  • [48] Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program
    Bertho, Marion
    Fraisse, Julien
    Patsouris, Anne
    Cottu, Paul
    Arnedos, Monica
    Perol, David
    Jaffre, Anne
    Goncalves, Anthony
    Lebitasy, Marie-Paule
    D'Hondt, Veronique
    Dalenc, Florence
    Ferrero, Jean-Marc
    Levy, Christelle
    Dabakuyo, Sandrine
    Rouzier, Roman
    Penault-Llorca, Frederique
    Uwer, Lionel
    Eymard, Jean-Christophe
    Breton, Mathias
    Chevrot, Michael
    Thureau, Sebastien
    Petit, Thierry
    Simon, Gaetane
    Frenel, Jean-Sebastien
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [49] Impact of Primary Site Surgery on Survival of Patients with de novo Stage IV Breast Cancer
    Huang, Zhen
    Tan, Qixing
    Qin, Qinghong
    Mo, Qinguo
    Wei, Changyuan
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 319 - 327
  • [50] BONE-ONLY VERSUS VISCERAL-ONLY METASTATIC PATTERN IN BREAST-CANCER - ANALYSIS OF 150 PATIENTS - A GOCS STUDY
    PEREZ, JE
    MACHIAVELLI, M
    LEONE, BA
    ROMERO, A
    RABINOVICH, MG
    VALLEJO, CT
    BIANCO, A
    RODRIGUEZ, R
    CUEVAS, MA
    ALVAREZ, LA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (04): : 294 - 298
12345